Impelpharma
Founded 2008 · 42 employees on LinkedIn · 3 known investors
Impel Pharmaceuticals develops therapies for patients using its drug delivery technology and expertise with small and large molecules. The company pursues partnerships, collaborations, and licensing opportunities to expand the therapeutic applications of its technology.
Investors · 3
Frequently asked questions
- What does Impelpharma do?
- Impel Pharmaceuticals develops therapies for patients using its drug delivery technology and expertise with small and large molecules. The company pursues partnerships, collaborations, and licensing opportunities to expand the therapeutic applications of its technology.
- Who are Impelpharma's investors?
- Impelpharma's investors include Cowles Ventures, Norwest Venture Partners, venBio Partners.